Table 3.
Variable | TTF | OS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
ALC > 1500/μL versus ALC ≤ 1500/μL | 0.53 | 0.32–0.88 | 0.013 | 0.44 | 0.23–0.82 | 0.010 |
NLR ≤ 3 versus NLR > 3 | 0.63 | 0.43–0.94 | 0.023 | 0.62 | 0.39–0.99 | 0.045 |
PLR ≤ 300 versus PLR > 300 | 0.51 | 0.33–0.81 | 0.004 | 0.63 | 0.38–1.02 | 0.062 |
LMR > 3 versus LMR ≤ 3 | 0.70 | 0.47–1.03 | 0.069 | 0.60 | 0.38–0.96 | 0.034 |
ALC absolute lymphocyte count, CI confidence interval, HR hazard ratio, LMR lymphocyte-to-monocyte ratio, NLR neutrophil-to-lymphocyte ratio, OS overall survival, PLR platelet-to-lymphocyte ratio, TTF time to treatment failure.